基本信息
浏览量:185
职业迁徙
个人简介
AWARDS AND CREDENTIALS
REGIONAL GUIDES
New York Magazine: Top Doctors: 2016, 2017, 2018, 2019, 2020, 2021
Castle Connolly Regional Top Doctors: 1st Edition
Top Doctors New York Metro Area (digital guide): 2016, 2017, 2018, 2019, 2020, 2021
Exceptional Women In Medicine: 2019, 2020
I am a board-certified surgeon with advanced training in minimally invasive techniques (laparoscopy and robotic surgery). I am dedicated to applying my technical expertise and clinical interests primarily to patients with stomach (gastric) cancer and adrenal tumors.
I am a member of Memorial Sloan Kettering’s Gastric Disease Management Team — a multidisciplinary team of surgeons, medical oncologists, pathologists, and other medical professionals who specialize in the diagnosis and treatment of gastric cancer. The combined expertise of our specialized team allows us to come up with the best plan for each patient.
In treating someone with stomach cancer, my goal is both to cure the patient of cancer and preserve his or her quality of life, both in the short and long term. I take all clinical data into account and select a surgical approach that has the greatest chance of accomplishing both goals.
In 2005, I introduced laparoscopic surgery as an option for patients with gastric cancer, and in 2009 I published the results of this approach in the Annals of Surgical Oncology. My research showed that the minimally invasive approach produces success rates comparable to those of traditional open surgery, with fewer complications, less blood loss and post-operative pain, and a shorter hospital stay. Laparoscopic surgery is an excellent approach for some, but not all, patients with the disease. I also developed a program in robotic gastrectomy in 2009, and apply this technique for selected patients. Results are promising and show decreased pain and quicker recovery for patients.
My research focuses not only on minimally invasive approaches and new technologies to better treat patients with gastric cancer, but also on molecular and genetic factors that may explain why some stomach cancers behave differently than others. I am particularly interested in differences in gastric cancer in the United States compared to Asian countries, and I am collaborating on an international level with gastric cancer surgeons in other countries to study this question. At Memorial Sloan Kettering, I am also working with pathologists and basic science researchers to study basic genetic factors that explain differences in certain types of gastric cancer, including questions relating to other gastric tumors, such as gastric gastrointestinal stromal tumors (GIST) and gastric carcinoids.
On a national and international level, I am a member of the National Comprehensive Cancer Network (NCCN) Esophageal and Gastric Advisory Group, which establishes the national guidelines for hospitals across the country regarding recommended standards to diagnose and treat gastric cancer. I have lectured at gastric cancer specialty meetings in Asia and Europe, including the International Gastric Cancer Congress (IGCC) Meeting in 2009, on novel research and minimally invasive surgery for this disease.
I also treat patients with adrenal tumors, and since 2005, I have overseen the adrenal database at Memorial Sloan Kettering, forming connections with endocrinologists, pathologists, and medical oncologists who share an interest in adrenal disorders. I have lectured internationally and published about laparoscopic adrenalectomy, which is the minimally invasive removal of tumors of the adrenal gland. I also treat patients with tumors that have metastasized from other primary sites to the adrenal gland, and have studied and published the collective experience of surgeons at Memorial Sloan Kettering to help better understand who is most suited for surgical removal of these tumors. I have also performed studies to define how patients with pheochromocytoma (a hormone-producing tumor of the adrenal gland) should be followed and how to determine if such tumors may recur.
Minimally invasive techniques may be appropriate for patients with cancerous and pre-cancerous disorders of the distal pancreas, spleen, and small intestine, and I have expertise in laparoscopic surgery for these problems as well.
I typically see new patients on Tuesdays at our 53rd Street location and operate on Mondays and Thursdays. I spend the remainder of my time conducting research, teaching, and lecturing. My contact information is listed below.
Working at a place like Memorial Sloan Kettering is a privilege and it is clear that the patients expect the very best from their physicians. It is gratifying to know you have helped a cancer patient through a part of their treatment and that you may have helped cure them. The hope is to allow people to return to normal life as soon as possible.
REGIONAL GUIDES
New York Magazine: Top Doctors: 2016, 2017, 2018, 2019, 2020, 2021
Castle Connolly Regional Top Doctors: 1st Edition
Top Doctors New York Metro Area (digital guide): 2016, 2017, 2018, 2019, 2020, 2021
Exceptional Women In Medicine: 2019, 2020
I am a board-certified surgeon with advanced training in minimally invasive techniques (laparoscopy and robotic surgery). I am dedicated to applying my technical expertise and clinical interests primarily to patients with stomach (gastric) cancer and adrenal tumors.
I am a member of Memorial Sloan Kettering’s Gastric Disease Management Team — a multidisciplinary team of surgeons, medical oncologists, pathologists, and other medical professionals who specialize in the diagnosis and treatment of gastric cancer. The combined expertise of our specialized team allows us to come up with the best plan for each patient.
In treating someone with stomach cancer, my goal is both to cure the patient of cancer and preserve his or her quality of life, both in the short and long term. I take all clinical data into account and select a surgical approach that has the greatest chance of accomplishing both goals.
In 2005, I introduced laparoscopic surgery as an option for patients with gastric cancer, and in 2009 I published the results of this approach in the Annals of Surgical Oncology. My research showed that the minimally invasive approach produces success rates comparable to those of traditional open surgery, with fewer complications, less blood loss and post-operative pain, and a shorter hospital stay. Laparoscopic surgery is an excellent approach for some, but not all, patients with the disease. I also developed a program in robotic gastrectomy in 2009, and apply this technique for selected patients. Results are promising and show decreased pain and quicker recovery for patients.
My research focuses not only on minimally invasive approaches and new technologies to better treat patients with gastric cancer, but also on molecular and genetic factors that may explain why some stomach cancers behave differently than others. I am particularly interested in differences in gastric cancer in the United States compared to Asian countries, and I am collaborating on an international level with gastric cancer surgeons in other countries to study this question. At Memorial Sloan Kettering, I am also working with pathologists and basic science researchers to study basic genetic factors that explain differences in certain types of gastric cancer, including questions relating to other gastric tumors, such as gastric gastrointestinal stromal tumors (GIST) and gastric carcinoids.
On a national and international level, I am a member of the National Comprehensive Cancer Network (NCCN) Esophageal and Gastric Advisory Group, which establishes the national guidelines for hospitals across the country regarding recommended standards to diagnose and treat gastric cancer. I have lectured at gastric cancer specialty meetings in Asia and Europe, including the International Gastric Cancer Congress (IGCC) Meeting in 2009, on novel research and minimally invasive surgery for this disease.
I also treat patients with adrenal tumors, and since 2005, I have overseen the adrenal database at Memorial Sloan Kettering, forming connections with endocrinologists, pathologists, and medical oncologists who share an interest in adrenal disorders. I have lectured internationally and published about laparoscopic adrenalectomy, which is the minimally invasive removal of tumors of the adrenal gland. I also treat patients with tumors that have metastasized from other primary sites to the adrenal gland, and have studied and published the collective experience of surgeons at Memorial Sloan Kettering to help better understand who is most suited for surgical removal of these tumors. I have also performed studies to define how patients with pheochromocytoma (a hormone-producing tumor of the adrenal gland) should be followed and how to determine if such tumors may recur.
Minimally invasive techniques may be appropriate for patients with cancerous and pre-cancerous disorders of the distal pancreas, spleen, and small intestine, and I have expertise in laparoscopic surgery for these problems as well.
I typically see new patients on Tuesdays at our 53rd Street location and operate on Mondays and Thursdays. I spend the remainder of my time conducting research, teaching, and lecturing. My contact information is listed below.
Working at a place like Memorial Sloan Kettering is a privilege and it is clear that the patients expect the very best from their physicians. It is gratifying to know you have helped a cancer patient through a part of their treatment and that you may have helped cure them. The hope is to allow people to return to normal life as soon as possible.
研究兴趣
论文共 287 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Melissa A. Lumish,Henry Walch,Steven B. Maron,Walid Chatila,Yelena Kemel,Anna Maio,Geoffrey Y. Ku,David H. Ilson,Elizabeth Won,Jia Li,Smita S. Joshi,Ping Gu,Mark A. Schattner,Monika Laszkowska,Hans Gerdes,David R. Jones,Smita Sihag,Daniel G. Coit,Laura H. Tang,Vivian E. Strong,Daniela Molena, Zsofia K. Stadler,Nikolaus Schultz,Yelena Y. Janjigian,Andrea Cercek
ANNALS OF SURGICAL ONCOLOGYno. 1 (2024): S76-S76
引用0浏览0引用
0
0
Annals of surgery (2024)
Patrick T. Magahis,Nicole Cornet,Laura H. Tang, Kanika Aurora,Neha Hingorani,Stephanie King,Arnold J. Markowitz,Mark A. Schattner,Shoji Shimada,Steven B. Maron,Santosha Vardhana,Melissa A. Lumish,Andrea Cercek,Yelena Janjigian,Daniel Coit,Robin Mendelsohn,Michael Berger,Vivian E. Strong, Zsofia Stadler,Monika Laszkowska
Gastroenterologyno. 5 (2024): S-994-S-995
CANCERno. 13 (2024): 2253-2256
Sean J. Judge, Sofia V. Gearty,Amanda Catchings,Megha Ranganathan, Michael H. Roehrl,Santosha A. Vardhana,Laura Tang, Zsofia K. Stadler,Vivian E. Strong
JCO PRECISION ONCOLOGY (2024)
Emily E Stroobant,Vivian E Strong
Hematology/oncology clinics of North Americano. 3 (2024): 547-557
Marion Liu,Vivian Strong
JAMA surgeryno. 8 (2024): 908-909
JAMA SURGERYno. 7 (2024): 755-755
Miseker Abate,Harrison Drebin,Shoji Shimada,Teng Fei,Sophia McKinley, Katherine Poruk, Ben Ferguson,Madalyn Neuwirth,Laura H. Tang,Santosha Vardhana,Vivian E. Strong
Annals of surgical oncologyno. 10 (2024): 6959-6969
加载更多
作者统计
#Papers: 284
#Citation: 11182
H-Index: 51
G-Index: 103
Sociability: 7
Diversity: 3
Activity: 87
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn